Avivagen: Top 10 Undervalued Drug Manufacturers Industry Stocks (VIV)
Avivagen is now ranked among the top 10 undervalued stocks in the Drug Manufacturers industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below).
Drug Manufacturers: Major, global pharmaceutical manufacturers offering a broad and diverse line of drug and healthcare products; industry leaders that have made a significant commitment to the research and development of a long pipeline of drugs. Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| VIV-X | Avivagen | 0.01 | 0.04 | 0.03 (179.89) | 94,119 | 1.2 | 0 | 0 |
| OGI-T | OrganiGram Holdings | 0.66 | 1.53 | 0.87 (132.22) | 258,256 | 205.9 | 0 | 0 |
| NU-X | NeutriSci International | 0.01 | 0.02 | 0.01 (98.87) | 101,695 | 1.7 | 0 | 0 |
| ENTG-X | Entourage Health | 0.03 | 0.06 | 0.04 (141.37) | 79,854 | 7.6 | 0 | 0 |
| CWEB-T | Charlottes Web Holdings | 0.41 | 0.88 | 0.47 (113.21) | 37,588 | 60.9 | 0 | 0 |
| RTI-X | Radient Technologies | 0.01 | 0.01 | 0.01 (179.3) | 0 | 2.7 | 0 | 0 |
| CRON-T | Cronos Group | 2.39 | 4.42 | 2.03 (84.96) | 130,839 | 900.9 | 0 | 0 |
| INCR-U-T | Intercure | 2.33 | 4.48 | 2.15 (92.06) | 273 | 105.7 | 0 | 9.4 |
| KHRN-X | Khiron Life Sciences | 0.04 | 0.08 | 0.04 (99.87) | 236,028 | 8.6 | 0 | 0 |
| ROMJ-X | Rubicon Organics | 0.57 | 1.31 | 0.74 (129.24) | 14,032 | 32.3 | 0 | 0 |
More about Avivagen
All data provided as-at market close May 11, 2023. The list is sorted by stocks with the greatest percentage difference between valuation and price. Avivagen Avivagen Inc develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's own health defenses. Avivagen is listed under VIV on the TSX Venture Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs. StockCalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. StockCalc's Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including: Discounted Cash Flow (DCF), Price & Other Comparables, Multiples, Adjusted Book Value (ABV) and Analyst Consensus
Artificial intelligence at Report on Business
Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
